Mounjaro Solution for Injection
  1. Home
  2. Mounjaro
  3. Mounjaro Solution for Injection

Mounjaro Solution for Injection

Mounjaro Solution for Injection is a prescription dual GIP and GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is supplied as a sterile solution for once-weekly subcutaneous injection using a prefilled injection pen. The ready-to-use formulation provides convenient, accurate, and reliable dose administration.

BUY NOW

Category

Mounjaro Solution for Injection contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose and body weight by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The sterile solution is delivered through a prefilled injection pen designed for precise once-weekly subcutaneous administration and consistent therapeutic performance across multiple dosage strengths. Manufactured under stringent pharmaceutical quality standards, each prefilled pen is intended for single-patient use and offers dependable dose delivery throughout the prescribed treatment period. Mounjaro Solution for Injection should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro Solution for Injection
Active Ingredient Tirzepatide
Dosage Form Sterile Solution for Injection
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro Solution for Injection, Tirzepatide Solution for Injection, Mounjaro Injection, Tirzepatide Injectable, GIP GLP-1 Injection, Weekly Tirzepatide Injection, Mounjaro Prefilled Pen